Skip to content

Clinical trial of stereoelectroencephalography (SEEG) electrode

Clinical trial of stereoelectroencephalography(SEEG) electrode

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100047743
Enrollment
Unknown
Registered
2021-06-26
Start date
2018-07-06
Completion date
Unknown
Last updated
2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intractable epilepsy

Interventions

Sponsors

Xuanwu Hospital Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. aged 8 to 60 years; 2. Those with good compliance who can cooperate with the whole clinical trial; 3. Those who did not participate in other clinical trials within three months; 4. Those with epilepsy at least once a month; 5. Those who received regular antiepileptic drugs under the guidance of neurologists, failed to effectively control the seizure, and were diagnosed as drug refractory epilepsy; or those who needed surgery; 6. Those who can understand the purpose of the test, voluntarily participate in and sign the informed consent; 7. Those who are willing to follow up and evaluate according to the requirements of the validation scheme.

Exclusion criteria

Exclusion criteria: 1. Those with infection at the operation site; 2. Those with hemorrhagic constitution or coagulation dysfunction (prothrombin time Pt = 18S); 3. Those with allergy to implanted electrode; 4. Those are in critical condition and are difficult to make accurate evaluation on the effectiveness and safety of the device; 5. Those with mental illness, peptic ulcer or poor general condition; 6. Those with arrhythmia, asthma or active lung disease; 7. Those with insulin dependent diabetes; 8. Those with poor compliance judged by researchers and unable to complete the study as required;; 9. Women who are pregnant or have intention of pregnancy in the past half year, and lactating women; 10. Other subjects not suitable for the clinical trial judged by the researcher.

Design outcomes

Primary

MeasureTime frame
Success rate of EEG signal recording;Success rate of SEEG implantation;Success rate of Radiofrequency thermocoagulation;Product clinical evaluation;Device related AE;Laboratory examination;Occurrence rate of AE or SAE;

Secondary

MeasureTime frame
Rate of EEG signal change before and after Radiofrequency thermocoagulation;Evaluation of therapeutic effect of epilepsy;

Countries

China

Contacts

Public ContactYuping Wang

Xuanwu Hospital Capital Medical University

wangyuping01@sina.cn+86 01 83198277

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026